1 Organ Transplant Disruptor to Buy on the Dip
TransMedics (NASDAQ:TMDX) is an innovative biotechnology company that may well have the potential to disrupt the $11 billion organ transplant industry.
The company’s unique organ care system technology protects and monitors donor organs before they are transplanted into patients, resulting in improved organ health and outcomes. TransMedics also provides logistical services, including organ transportation through its fleet of 18 aircraft. » Read more about: 1 Organ Transplant Disruptor to Buy on the Dip »
Read More
Buffett’s Mystery Holding Unveiled: How To Play It
Speculation has been rife for some time about why Berkshire Hathaway requested special exemption from disclosure of a holding that most likely it has been building a position in.
Buffett knows as well as anyone that his holdings are carefully observed and many followers plough into them with abandon when revealed.
He also has admitted that so few purchases will move the needle for Berkshire now that it’s like trying to find a needle in a haystack.
» Read more about: Buffett’s Mystery Holding Unveiled: How To Play It »
Read More
Best Trader Ever Says AI Will…
Stanley Druckenmiller is arguably the best trader in the world not because of the 30% returns he posted annualized on average over 30 years but because during that time frame he never had a losing year.
It would be nice to invest alongside him but those days are gone, because he now manages a Family Office only,
» Read more about: Best Trader Ever Says AI Will… »
Read More
Is This Space Stock Set For Blast Off?
It’s not every day of the week we cover stocks trading under $5 per share, which are technically considered penny stocks. It’s rarer still to discuss those trading under $2 per share, but one space stock now is just too interesting to gloss past.
Before proceeding further, we must first note that this stock has been nothing short of a train wreck for shareholders since first going public via a SPAC sponsored by dMY Technology Group.
» Read more about: Is This Space Stock Set For Blast Off? »
Read More
Is Tesla In Nose-Bleed Territory?
Tesla has had a scintillating run since Election Day with the stock rallying from the low $220 region all the way towards $350+ in a matter of days.
Having run so far so fast, what are the odds Tesla share price is set to correct soon? How high is too high for Tesla stock price?
» Read more about: Is Tesla In Nose-Bleed Territory? »
Read MoreThe Ivy
Is Another NVIDIA Stock Split Imminent?
NVIDIA has split its stock six times during its 25 years as a public company. The first stock split happened in 2001, and it doubled the number of shares available. If you owned 100 Nvidia shares before the split, you had 200 shares after. The most recent stock split occurred on May 22, 2024 and was 10:1 meaning for every 100 shares owned on May 21,
» Read more about: Is Another NVIDIA Stock Split Imminent? »
Read MoreThe Spotlight
1 Stock Buffett Likes More Than Apple
Stocks have pulled back in the past month, as interest rates and inflation continue to dog the market. The AI excitement that gripped investors earlier in the year has abated somewhat, leading to recent pullbacks in stocks like Nvidia and Microsoft.
Apple has struggled to make an impact with investors because the company has lagged behind its competitors in launching AI-powered products.
» Read more about: 1 Stock Buffett Likes More Than Apple »
Read MoreThe Daily
What will impact US markets this week? 5 factors to watch
US stock futures surged on Monday, signaling a potential rebound from recent losses as investors assessed the impact of President Trump’s trade overhaul on Nvidia (NVDA) ahead of its upcoming earnings report. Futures tied to the Dow Jones Industrial Average rose 0.8%, recovering from its worst week since October. Meanwhile, S&P 500 futures gained 0.5%,
» Read more about: What will impact US markets this week? 5 factors to watch »